mats-ola s kalgraff uretra lower urinary tract symptoms revisited: a broader clinical perspective....
TRANSCRIPT
![Page 1: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/1.jpg)
![Page 2: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/2.jpg)
![Page 3: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/3.jpg)
Mats-Ola S Kalgraff • M.D Umeå University Sweden
• Master in Sexology Aalborg University Denmark
• Volvat Med Senter Oslo
• Ferring Scandinavia
• Kristiansund Hospital Chief of Urology Department
• Avtalehjemmel Urologi Moelv
• Avtalehjemmel Urologi Brumundal. Multidisciniplenary team
• Mosjøen og Haugesund Overlege urologi
![Page 4: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/4.jpg)
![Page 5: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/5.jpg)
![Page 6: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/6.jpg)
ED, kommer med sykdom, ikke med alder !
Med alder kommer sykdom !!!
![Page 7: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/7.jpg)
En God Erektion Kräver
Lust och Tillgång på Sexuella känslor Kognitiva funktioner Intakt nerv kommunikation CNS – periferi Responsiv glatt muskulatur i Penis Fungerande Endotelial reglering av kärltonus Testosteron i tillräcklig mängd Thyreoidea funktion i god ordning
![Page 8: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/8.jpg)
Billups K, Friedrich S. Presenterat på: AUA; maj 2000; Atlanta, Ga. J Urol. 2000;163(4) Abstract 655. Braun M et al. Int J Impot Res. 2000;12:305–311. Burchardt M et al. J Urol. 2000;164:1188–1191. Levine L, Kloner R. Am J Cardiol. 2000;86:1210–1213. Pritzker MR. Circulation. 1999;100(suppl I):I-711. Abstract 3751. Seftel A. J Urol. 2004;171:2341–2345.
• 68 % av män med hypertoni har ED
• 60 % av män med ED har dyslipidemi
• 56 % av män med ED har positivt stresstest
• 40 % av män med ED har betydande koronarkärls-ocklusioner
• 20 % av män med ED har diabetes mellitus
• 11 % av män med ED har depression
ED har samband med andra allvarliga behandlingsbara sjukdomar
![Page 9: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/9.jpg)
Er mannen før kort for sin vekt?
menn dør unge og har kortere levetid
![Page 10: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/10.jpg)
![Page 11: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/11.jpg)
Menn tilsynelatende så lik men allikevel så ulik !
??????
![Page 12: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/12.jpg)
![Page 13: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/13.jpg)
![Page 14: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/14.jpg)
HUSK DISSE
![Page 15: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/15.jpg)
![Page 16: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/16.jpg)
3.1.5 Risk Factors and underlying causes
3.1.5.1 Risk factors
Risk factors include many different factors from various areas,
including genetic, psychological state,
recurrent physical trauma and endocrine factors.
Chronic pelvic pain
CPPS og prostatit ses frekvent hos hypogonade menn
ISSM Dean
![Page 17: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/17.jpg)
![Page 18: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/18.jpg)
![Page 19: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/19.jpg)
refguidelines eua /CPPS
![Page 20: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/20.jpg)
Detrusor
overaktivi
tet
BPH
Blære
Tumor
Stein
Nedre
urinveier
Ned
re
Annet
Neurolog
isk
sykdom
Kronisk
e
bekken
smerter
Nocturn
polyuri
OAB
Fremmen
de
Kropp
UVI
Striktur
Uretra
![Page 21: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/21.jpg)
Lower urinary tract symptoms revisited: a broader clinical perspective.
Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT, Roehrborn CG.
Author information Abstract
CONTEXT:
The term "lower urinary tract symptoms" (LUTS) was introduced to dissociate male urinary symptoms from any implied site of symptom origin, such as the prostate.
OBJECTIVE:
To consider a more expansive view of LUTS, moving beyond an organocentric focus.
EVIDENCE ACQUISITION:
Review of the available literature by a consensus panel.
EVIDENCE SYNTHESIS:
A consensus group reviewed the literature and developed a conceptual framework to facilitate research and clinical practice in patients with LUTS, following steps outlined in the Delphi
procedure. Committee discussion, with presentations and review of existing literature and knowledge at four separate occasions, and extensive review and discussion of draft documents
encapsulating group views followed. Consensus group findings included evidence that LUTS increase with age and are prevalent in both male and female patients, with differences in the
prevalence of individual storage, voiding, and postmicturition symptoms representing underlying pathophysiologic factors between the sexes. Additionally, it was recognised that patients
often have underlying and overlapping pathophysiologic mechanisms that may be related to the expression of LUTS and that this global approach to LUTS reflects our contemporary
recognition of the lower urinary tract as an integrated functional unit. To improve the current management of patients, education and awareness regarding LUTS, its causes, and
associated comorbidities are needed. Major limitations of this work are the potential interpretive bias introduced by prior perceptions and the nature of the study populations drawn
conventionally from secondary care.
CONCLUSIONS:
In conclusion, it is misleading to attribute individual symptoms to sex differences or to a specific underlying
organ. LUTS are a non-sex-specific, non-organ-specific group of symptoms, which are sometimes age-
related and progressive. A need exists to increase education and awareness regarding LUTS, its causes, and
associated comorbidities, and to assess and treat men and women for all LUTS, not just selected symptoms.
PMID: 18423969 DOI: 10.1016/j.eururo.2008.03.109
![Page 22: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/22.jpg)
Noen av de mest vanlige tilstanden før LUTS hos menn presentert her nedenfor
Akutt urinretensjon, smertefull palpabel eller perkutorisk blære, når pas ikke kan urinere
Kronisk retensjon ; ikke smertefull blære som man kan palpere eller perkutere etter det at
pas har latet vannet, ofte er pas inkontinent
Bladder outlet obstruction BOO
en term før obstruksjon under tømming, karakteristisk er økt detrusor trykk og svak stråle
Benign prostatic obstruction BPO er en variant av BOO .
BPH er eg en histologisk beskrivning
Detrusor overactivity (DO) er en urodynamisk observation karakterisert av ikke frivillige
sammentrekninger av blærens muskulatur under fyllnadsfas, Disse kan være spontane eller
fremprovosert
Overactive bladder syndrome OAB karakterisert av urge med eller uten inkontinens with or
without urgency urinary incontinence, vanlitvis med økt frekvens av tømminger dagtid og
nattlig urinering ,om man ikke funnet infeksjon eller annen åpenlys grunn til sykdom.
![Page 23: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/23.jpg)
Man eller Kvinne ?
![Page 24: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/24.jpg)
![Page 25: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/25.jpg)
![Page 26: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/26.jpg)
![Page 27: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/27.jpg)
void
ing
-slo
w s
tream
-sp
litting o
r spra
yin
g
-in
term
itte
ncy
-str
ain
ing
-te
rmin
al dribblin
g
voiding
-slow stream
-splitting or spraying
-intermittency
-straining
-terminal dribbling
post micturition
-post micturition dribble
-feeling of incomplete emptying
storage
-frequency
-urgency
-nocturia
-incontinence
![Page 28: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/28.jpg)
○ IPSS
○ 7 spørsmål tømmer du deg?
○ Mindre tid en 2 timer mellon urinering
○ Må du stoppe og starte flere ggr under vannlating
○ Er det vanskelig att utsette vannlating
○ Har du svak stråle
○ Må du presse?
○ Hvor ofte tisser du om tisse om natten
○ X/35
○ QoL skala 1-6
○ 4
21/35
![Page 29: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/29.jpg)
○ QoL skala 1-6
○ EN PAS SCORER IPSS 4/35 QoL 6/6
○ VAD KAN JEG GJØRE FOR DEG SÅ AT DU
SCORER 1 ?
Spør
![Page 30: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/30.jpg)
![Page 31: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/31.jpg)
Fortell meg
At jeg ikke har kreft !
![Page 32: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/32.jpg)
Post voidal residual
![Page 33: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/33.jpg)
Downloaded from: Campbell-Walsh Urology (on 28 January 2010 09:32 AM)
© 2007 Elsevier
![Page 34: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/34.jpg)
![Page 35: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/35.jpg)
Per Rectum
Two reasons to not palpate the prostate
• No finger
• No hole
![Page 36: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/36.jpg)
Brown finger Award
DRU Digital rektal
undersökelse
![Page 37: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/37.jpg)
Transrektalt ultralyd • EKO
• Størrelse
• Vevsprøve
![Page 38: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/38.jpg)
38
Signalerer aktivitet i prostata
• Har man prostata har man PSA
• Kan vara kreft
• Infeksjon, stor kjertel , kateter ,
vevsprøve , sykling, sexleketøy
PSA; PROSTATA SPECIFIKT ANTIGEN
![Page 39: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/39.jpg)
Patients with Pca
Pat LUTS
All men with prostate
No prostate
![Page 40: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/40.jpg)
PSA Velocity
• Med vilken hastighet
PSA ökar med tiden
• >0.75ug/l och år
0,
1,3
2,5
3,8
5,
2004 2005 2006 2007
pat 1
pat 2
![Page 41: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/41.jpg)
TRUL
• Volume
• 5 i PSA
• 20ml vs 80 ml
• Densitet PSA/ML >0,15 indicates cancer
41
![Page 42: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/42.jpg)
Tabell 3: Risiko for prostatakreft sammenholdt med lave PSA verdier.
PSA nivå (ng/ml) Risiko for prostatakreft
0-0,5 6,6% 0,6-1 10,1% 1,1-2 17,0% 2,1-3 23%
3,1-4 26,9%
”US prevention study” (Thompson et al.,
2004). Frekvensen av prostatakreft
sammenholdt med serum PSA hos 2950
menn i placebo-armen og med normal
PSA-verdier vises i Tabell 3. Alders
spredningen ved biopsi var 62-91 år.
![Page 43: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/43.jpg)
Duodart
kombinasjon tamsulosin og dutasteride
Proscar
Finasteride
HUSK
Tamsulosin minker ikke prostata
Finasteride og dutasteride minker volum
![Page 44: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/44.jpg)
5 overflow
![Page 45: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/45.jpg)
Makroskopisk hematuri
![Page 46: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/46.jpg)
Overflow
IKKE FRIVILLIG LEKKASJE FOR URIN.
SPESIELLT OM NATTEN
Pasienten ser gravid ut
FARLIG !
Nyresvikt
Øvre urinveisinfektion
Sett kateter,
UNDERSØK PAS NØYE ETTERPÅ
![Page 47: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/47.jpg)
Makroskopisk Hematuri
• Blod synlig for øye
• Er alltid sant !
• Er kreft til motsatt er bevist
• Cystoskopi
CT scan
![Page 48: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/48.jpg)
Prostata
BPH
alfablokkad
femalfareduktashemmer
kombo
kirurgi
Prostatitt
NSAID
AlfaBlokkad
Tricykliske antidepressive
Antibiotika ?
PCa
helt eget foredrag
![Page 49: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/49.jpg)
Blære
stein
tumor
oab
neurogen skade
inkontinens ufrivillig NB!
IC ??
![Page 50: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/50.jpg)
Skrotum
hydrocele
varicocele
orkitt
spermatocele
tumor( unge menn)
epididydimitt
![Page 51: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/51.jpg)
Penis/uretra
Peyronies
Striktur
uretritt
peniskreft meget uvanlig i vest
fimose
![Page 52: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/52.jpg)
Etter sterilisering/vasektomi
Blødning
Infeksjon
skrotala smerter
er også diskutert i sammenheng med
prostatkreft - når er der ingen link ?
alzheimer-link?
metabole sykdommer —finnes link ?
hypogonadisme-link?
hypogonadisme er linket til prostatkreft
forskningstes
vasektomi—hypogonadisme—prostatakreft
![Page 53: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/53.jpg)
![Page 54: Mats-Ola S Kalgraff Uretra Lower urinary tract symptoms revisited: a broader clinical perspective. Chapple CR1, Wein AJ, Abrams P, Dmochowski RR, Giuliano F, Kaplan SA, McVary KT,](https://reader031.vdocuments.mx/reader031/viewer/2022013110/5c90b52109d3f242278bbdad/html5/thumbnails/54.jpg)